Position in SCYX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$311,456
+$105,462 QoQ
Shares Held
76,525
+172.5% QoQ
Ownership
0.769%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 39 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. SCYX ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in SCYX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $311,456 | 76,525 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $205,994 | 224,640 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $111,232 | 176,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $134,442 | 174,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $107,865 | 159,800 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $150,035 | 157,600 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $180,411 | 149,100 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $217,093 | 145,700 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $278,000 | 139,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $523,672 | 356,240 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $514,996 | 230,940 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $123,667 | 54,240 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $562,211 | 190,580 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $51,300 | 17,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,160 | 11,000 | Shares | Sole | 2023-02-13 | |
| 2020-12-31 | $990,261 | 129,446 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $181,220 | 41,093 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $488,331 | 650,242 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $352,824 | 451,760 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||